XML 29 R19.htm IDEA: XBRL DOCUMENT
v3.23.2

Net Loss Per Share | 6 Months Ended
--- | ---
Jun. 30, 2023
Earnings Per Share [Abstract] |
Net Loss Per Share | 12. Net Loss Per Share Basic and diluted net loss per share were calculated as follows: The numerator for basic and diluted net loss per share is as follows for the three and six months ended June 30, 2023 and 2022: Schedule of Numerator for Basic and Diluted Net Loss Per Share
|  | 2023 |  |  | 2022 |  |  | 2023 |  |  | 2022 |
|  | Three Months Ended |  |  | Six Months Ended |
|  | 2023 |  |  | 2022 |  |  | 2023 |  |  | 2022 |
Net loss |  | $ | (4,429,528 | ) |  | $ | (1,890,153 | ) |  | $ | (6,886,707 | ) |  | $ | (4,216,170 | )
Dividends on preferred stock |  |  | (643,267 | ) |  |  | (692,246 | ) |  |  | (1,355,347 | ) |  |  | (1,384,492 | )
Net loss attributable to common shareholders |  | $ | (5,072,795 | ) |  | $ | (2,582,399 | ) |  | $ | (8,242,054 | ) |  | $ | (5,600,662 | )
The denominator is as follows for the three and six months ended June 30, 2023 and 2022: Schedule of Numerator for Basic and Diluted Weighted Average Common Stock Outstanding
|  | Three Months Ended |  |  | Six Months Ended |
|  | 2023 |  |  | 2022 |  |  | 2023 |  |  | 2022 |
Weighted average common stock outstanding, basic and diluted |  |  | 2,137,207 |  |  |  | 1,043,988 |  |  |  | 1,593,617 |  |  |  | 1,043,870 |
$0.01 warrants |  |  | 10,319 |  |  |  | 11,466 |  |  |  | 10,893 |  |  |  | 11,466 |
Total |  |  | 2,147,526 |  |  |  | 1,055,454 |  |  |  | 1,604,510 |  |  |  | 1,055,336 |
Net loss per share, basic and diluted is as follows for the three and six months ended June 30, 2023 and 2022: Schedule of Net Loss Per Share, Basic and Diluted
|  | Three Months Ended |  |  | Six Months Ended |
|  | 2023 |  |  | 2022 |  |  | 2023 |  |  | 2022 |
Net loss per share, basic and diluted |  | $ | (2.36 | ) |  | $ | (2.45 | ) |  | $ | (5.14 | ) |  | $ | (5.31 | )
The following potential common stock equivalents, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect: Schedule of Calculation of Diluted Net Loss Per Share
|  | 2023 |  |  | 2022 |
|  | June 30, |
|  | 2023 |  |  | 2022 |
Options to purchase shares of common stock |  |  | 1,260,681 |  |  |  | 1,290,318 |
Warrants outstanding |  |  | 323,733 |  |  |  | 263,743 |
Common stock reserved for future issuance |  |  | 1,584,414 |  |  |  | 1,554,061 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration